Clinical Trial Update: Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial results for pegylated interferon plus ribavirin to treat chronic hepatitis C, including patients with and without kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED | Results posted: 2013-11-08